Hansa Biopharma AB (publ) (STO:HNSA)
Sweden · Delayed Price · Currency is SEK 36.10
-0.02 (-0.06%)
Oct 13, 2026, 11:39 AM CET
Hansa Biopharma AB Market Cap
Hansa Biopharma AB has a market cap or net worth of 3.67 billion as of October 12, 2026. It is the 16,970th most valuable company in the world and the 211th biggest in Sweden. Its market cap has decreased by 6.48% in one year.
Market Cap
3.67B
Enterprise Value
4.15B
Revenue
189.46M
Global Rank
Country Rank
#211 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 24, 2008, Hansa Biopharma AB's market cap has increased from 30.71M to 3.67B, an increase of 11,861.50%. That is a compound annual growth rate of 29.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 3.67B | 5.06% |
| Dec 30, 2025 | 3.50B | 31.53% |
| Dec 30, 2024 | 2.66B | 93.47% |
| Dec 29, 2023 | 1.37B | -46.77% |
| Dec 30, 2022 | 2.58B | -34.64% |
| Dec 30, 2021 | 3.95B | -63.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Egetis Therapeutics AB | 4.62B |
| Vicore Pharma Holding AB | 2.53B |
| BioInvent International AB | 1.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Flerie AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |